SLC5A2 and hydrops fetalis: Despite this progress, most of the evidence supporting these agents, particularly ARNIs and SGLT2 inhibitors, originates from HFrEF populations, although both have also shown the capacity to reduce HHF in HF with preserved ejection fraction (HFpEF).